Diclofenac induced gastrointestinal and renal toxicity is alleviated by thymoquinone treatment
- 31 July 2018
- journal article
- research article
- Published by Elsevier BV in Food and Chemical Toxicology
- Vol. 118, 795-804
- https://doi.org/10.1016/j.fct.2018.06.038
Abstract
No abstract availableKeywords
Funding Information
- Akdeniz University Research Foundation (TSA-2017-2545)
This publication has 50 references indexed in Scilit:
- NSAID gastropathy and enteropathy: distinct pathogenesis likely necessitates distinct prevention strategiesBritish Journal of Pharmacology, 2011
- Diclofenac metabolism in the mouse: Novelin vivometabolites identified by high performance liquid chromatography coupled to linear ion trap mass spectrometryXenobiotica, 2011
- Topical diclofenac epolamine patch 1.3% for treatment of acute pain caused by soft tissue injuryInternational Journal of Clinical Practice, 2010
- Strategies to optimize treatment with NSAIDs in patients at risk for gastrointestinal and cardiovascular adverse eventsClinical Therapeutics, 2010
- Effect of resveratrol on tubular damage and interstitial fibrosis in kidneys of rats exposed to cigarette smokeToxicology and Industrial Health, 2009
- MINIMAL CHANGE DISEASE AND ACUTE TUBULAR NECROSIS CAUSED BY DICLOFENACNephrology, 2008
- Hepatic disorders in patients treated with COX-2 selective inhibitors or nonselective NSAIDs: A case/noncase analysis of spontaneous reportsClinical Therapeutics, 2006
- Hepatic adducts, circulating antibodies, and cytokine polymorphisms in patients with diclofenac hepatotoxicityHepatology, 2004
- Clinical Pharmacokinetics of DiclofenacClinical Pharmacokinetics, 1997
- Nonsteroidal antiinflammatory drug–induced enteropathy and severe chronic anemia in a patient with rheumatoid arthritisArthritis & Rheumatism, 1996